Viewing Study NCT00707967


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-05-20 @ 9:44 PM
Study NCT ID: NCT00707967
Status: COMPLETED
Last Update Posted: 2018-08-24
First Post: 2008-06-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 111517
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators